Supplier site
Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Semalytix

Semalytix is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small business

Clinical Consulting

Clinical Protocol Design & Development Creation of clinical protocol document which details how a clinical trial is designed, relating to to the methodology, hypothesis, and operation of clinical trial to ensure the safety of the patients is...
Clinical Trial Consulting Consulting services for Clinical trials.
Clinical Trial Recruitment Recruitment, enrollment and retention of patients for clinical trials.
Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.

Clinical Trials

Clinical Trial Risk Management Plan that maintains treatment quality throughout lifecycle and improve decision making.
Patient Recruitment Recruit and retain patients for clinical trials.
Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.

Commercial Consulting

Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.

Drug Development

Consulting Services Work with consultants who provide expert advice in various areas of research and technology.

General Marketing

Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.

HEOR

Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.

Show all 10 in HEOR 4 more

Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Show all 114 services 98 more

Market Access

Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
Life Science Reports Life Science reports
Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.

Show all 14 in Market Access 8 more

Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
Pharmaceutical Reports Pharmaceutical Reports
Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting
Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...

Medical/Commercial

Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Old Category HEOR, RWE, Market Access

Data - Other Extract insights and patterns from large and complex datasets.
Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.

Primary Market Research

Adherence, Satisfaction, and Switch Behavior Studies Explores factors driving treatment compliance, satisfaction, and switching behavior. Guides patient support initiatives and product differentiation.
Advertising Testing (qual/quant) Assesses reactions to creative advertising materials using both qualitative and quantitative methods. Supports refinement of campaign assets before launch.
AI-Assisted Transcription/Insight Coding Uses machine learning to accelerate transcription and qualitative analysis. Reduces turnaround time while maintaining analytical depth.
Behavioral Segmentation Groups stakeholders based on their actions and choices rather than demographics. Enables precise targeting and tailored intervention strategies.
Competitive Intelligence and Message Recall Measures awareness of competitor messaging and materials among stakeholders. Informs counter-positioning and promotional strategy.
Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.

Show all 41 in Primary Market Research 35 more

Data Cleaning and Statistical Modeling Prepares raw datasets for analysis through validation, normalization, and advanced modeling. Ensures accuracy and enables robust, reproducible insight generation.
Digital Journey Explores the online behaviors and decision-making patterns of stakeholders. Informs digital strategy, content placement, and platform selection.
Endpoint Relevance Testing Tests how meaningful proposed trial endpoints are to stakeholders, especially payers and regulators. Informs protocol refinement and evidence strategy.
Ethnographic research (in-home, diary studies) Observational or self-reported research capturing real-world experiences in home or daily life contexts. Provides authentic behavioral data used for patient journey mapping and product usability evaluation.
Focus groups (in-person/virtual) Facilitated group discussions to evaluate reactions to concepts, messages, or services. Produces consensus insights and contrasting views used to refine strategy, materials, or offerings.
Forecast Input Generation Provides validated data points for input into financial or epidemiologic models. Supports accurate revenue, market share, and volume forecasting.
GDPR, HIPAA, BHBIA, EphMRA Compliance Ensures compliance with data privacy, ethical, and regional marketing research regulations. Mitigates legal risk and builds trust with participants and clients.
Generalists and specialists (e.g., oncologists, neurologists) Research targeting both broad-practice physicians and specialists to understand treatment preferences, diagnostic challenges, and clinical decision-making. Provides comparative insights for segmentation, messaging...
Growth Potential Quantifies market size, penetration rates, and uptake forecasts for new products or categories. Guides business development and portfolio prioritization.
Iterative concept/message testing with interim adjustments Tests concepts or materials in cycles with refinements after each round based on feedback. Delivers optimized content that evolves with stakeholder input.
Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
Launch Readiness Assessments Evaluates internal and external preparedness for product launch, including sales force, market awareness, and access environment. Identifies gaps and supports launch planning.
Lifecycle Extension Concept Testing Tests ideas for extending the commercial life of a product (e.g., new formulations, indications). Supports long-term planning and investment decisions.
Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.
Message / Claims testing Iterative research to assess clarity, relevance, and impact of key messages. Delivers validated communications that align with stakeholder expectations.
Name Testing - Market Research Tests product or brand names for memorability, appropriateness, and appeal across markets. Supports final naming decisions and regulatory readiness.
Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
Pediatric and Geriatric Populations - Market Research Research focused on age-specific needs and barriers in child or elderly populations, including caregivers and healthcare providers. Informs development of age-appropriate interventions, trial design, and support...
Persona Development Synthesizes qualitative and quantitative data to build detailed, actionable profiles of stakeholder archetypes. Supports targeted communications and segmentation strategies.
Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
Psychological Research Explores cognitive and emotional drivers of stakeholder behavior. Informs persuasive communication and behavior change strategies.
Segmentation and Profiling Divides target audiences into distinct groups based on attitudes, behaviours, or demographics. Informs tailored messaging and targeting strategies.
Sequential qual-quant studies Combines initial qualitative exploration with follow-up quantitative validation. Ensures both depth and scale in evaluating concepts, needs, or strategies.
Simulation Models (e.g., uptake models) Builds dynamic frameworks to simulate adoption, market share, or treatment behavior over time. Supports forecasting and strategic scenario planning.
Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.
Target Product Profile (TPP) Testing Tests stakeholder reactions to hypothetical product profiles across key attributes. Guides clinical development prioritization and access positioning.
Thematic Analysis Qualitative coding of transcripts or notes to identify recurring themes, patterns, and insights. Produces structured findings used to develop narratives and recommendations.
Touchpoint Analysis Maps where and how stakeholders interact with a brand or service across the journey. Identifies high-impact opportunities for engagement.
Tracking - Market Research Longitudinal studies that monitor key metrics like awareness, usage, and satisfaction over time. Supports campaign optimization and lifecycle planning.
Transcription and Translation (Multilingual) - Market Research Accurate transcription and translation of qualitative research data into target languages. Delivers clean, comparable transcripts for analysis across markets.
Trial Feasibility and Design Preference (HCP/patient) Gathers stakeholder input on protocol practicality, site selection, and enrollment design. Reduces recruitment barriers and aligns trials with real-world practice.
Unmet Need and SoC Validation Assesses perceived gaps in current standards of care and the need for new interventions. Supports value proposition development and market shaping.
Volumetric Modelling Uses quantitative data and assumptions to forecast product volume, uptake, and market share. Supports revenue projections and manufacturing planning.

Real World Evidence & Data

Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
Data Asset Validation Tools for validating that patient data and source has been accurately recorded.
Data Merging Tools for combining various data sets into a single data set. Includes data consolidation.
Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
Multi-Source Data Pools Multiple data sources aggregated into singular platforms for analysis. May or may not include real-time analytics capabilities.

Show all 24 in Real World Evidence & Data 18 more

Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
Retrospective Exploratory Studies Retrospective exploratory studies
RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
Patient Risk Management Identify, contain, and manage risks related to patient safety.
Post Authorization Efficacy Study (PAES) Answer uncertainties in efficacy of treatment, and improve understanding of treatment and the benefit-risk profile. These studies are specifically asked for by European Medicines Agency (EMA) to continually grant...
Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...

Scientific Data Services

Scientific Data Visualization Exploration and reporting of data by means of graphs and plots.

Website: semalytix.com

Germany Bielefeld 1 site

Work with Semalytix on Scientist.com

For prices, more details, or to contact Semalytix, visit Scientist.com.

View on Scientist.com